Cancer and pregnancy: The clinician's perspective

Obstetrical and Gynecological Survey

Volumn 69, Issue 5, 2014, Pages 277-286

  Dotters Katz, Sarah ^a   McNeil, Michael ^b   Limmer, Jane ^c   Kuller, Jeffrey ^d  

^a Department of Obstetrics and Gynecology ^*  (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO HOSPITAL   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ASPARAGINASE; BEVACIZUMAB; CAPECITABINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FLUOROURACIL; GADOLINIUM; GRANULOCYTE COLONY STIMULATING FACTOR; IRINOTECAN; METHOTREXATE; METOCLOPRAMIDE; ONDANSETRON; OXALIPLATIN; RADIOPHARMACEUTICAL AGENT; THYROTROPIN; VINCA ALKALOID;

ARTICLE; BONE SCINTISCANNING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILDHOOD CANCER; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; FETAL WELL BEING; GENERAL ANESTHESIA; GESTATIONAL AGE; HEMATOLOGIC MALIGNANCY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MATERNAL TREATMENT; MELANOMA; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANOGENESIS; POSITRON EMISSION TOMOGRAPHY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; PREMATURITY; RADIATION EXPOSURE; REGIONAL ANESTHESIA; SPONTANEOUS ABORTION; THYROID CANCER; BREAST NEOPLASMS; CANCER STAGING; COLONIC NEOPLASMS; DELIVERY; FEMALE; HEMATOLOGIC NEOPLASMS; PATHOLOGY; PREGNANCY COMPLICATIONS, NEOPLASTIC; SECONDARY; SKIN NEOPLASMS; THYROID NEOPLASMS;

BREAST NEOPLASMS; COLONIC NEOPLASMS; DELIVERY, OBSTETRIC; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MELANOMA; NEOPLASM STAGING; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; SKIN NEOPLASMS; THYROID NEOPLASMS;

EID: 84900461727     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0000000000000068     Document Type: Article

References (164)

1. Pentheroudakis G, Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer. 2006;42:126-140. (Pubitemid 43083481)
2. Weisz B, Schiff E, Lishner M. Cancer in pregnancy: maternal and fetal implications. Hum Reprod Update. 2001;7:384-393. (Pubitemid 32655324)
3. Antonelli NM, Dotters DJ, Katz VL, et al. Cancer in pregnancy: a review of the literature. Part I. Obst Gynecol Surv. 1996;51:125-134. (Pubitemid 26044399)
4. Amant F, Deckers S, Van Calsteren K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer. 2010;46:3158-3168.
5. Brenner B, Avivi I, Lishner M. Haematological cancers in pregnancy. Lancet. 2012;379:580-587.
6. Salani R, Billingsley CC, Crafton SM. Cancer and pregnancy: an overview for obstetricians and gynecologists. Am J Obstet Gynecol. 2013.
7. The American College of Obstetricians and Gynecologists. Guidelines for diagnostic imaging during pregnancy. Int J Gynaecol Obstet. 1995;51:288-291.
8. Isla A, Alvarez F, Gonzalez A, et al. Brain tumor and pregnancy. Obstet Gynecol. 1997;89:19-23. (Pubitemid 27024459)
9. McTiernan AM, Weiss NS, Daling JR. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am J Epidemiol. 1984;120:423-435. (Pubitemid 14032090)
10. Zwinkels H, Dorr J, Kloet F, et al. Pregnancy in women with gliomas: a case-series and review of the literature.JNeurooncol. 2013;115:293-301.
11. Zanotti-Fregonara P, Koroscil TM, Mantil J, et al. Radiation dose to the fetus from [(18)F]-FDG administration during the second trimester of pregnancy. Health Phys. 2012;102:217-219.
12. Blom JW, Doggen CJ, Osanto S, et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293:715-722. (Pubitemid 40216041)
13. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a populationbased case-control study. Arch InternMed. 2000;160:809-815. (Pubitemid 30165241)
14. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141 (suppl 2):e195S-e226S.
15. Mackenzie AP, Levine G, Garry D, et al. Glioblastoma multiforme in pregnancy. J Matern Fetal Neonatal Med. 2005;17:81-83. (Pubitemid 40515948)
16. Kuy S, Roman SA, Desai R, et al. Outcomes following thyroid and parathyroid surgery in pregnant women. Arch Surg. 2009;144:399-406; discussion 406.
17. Tan GH, Gharib H, Goellner JR, et al. Management of thyroid nodules in pregnancy. Arch Intern Med. 1996;156: 2317-2320. (Pubitemid 26395545)
18. Ezri T, Szmuk P, Evron S, et al. Difficult airway in obstetric anesthesia: a review. Obstet Gynecol Surv. 2001;56:631-641. (Pubitemid 32946156)
19. Gerstenfeld TS, Chang DT, Pliego AR, et al. Nonobstetrical abdominal surgery during pregnancy in Women's Hospital. J Matern Fetal Med. 2000;9:170-172. (Pubitemid 30451040)
20. Maxwell C, Barzilay B, Shah V, et al. Maternal and neonatal outcomes in pregnancies complicated by bone and softtissue tumors. Obstet Gynecol. 2004;104:344-348. (Pubitemid 40458882)
21. Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol. 1989;16:337-346. (Pubitemid 19259007)
22. Zemlickis D, Lishner M, Degendorfer P, et al. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med. 1992;152:573-576.
23. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5:283-291. (Pubitemid 38541580)
24. Zemlickis D, Lishner M, Degendorfer P, et al. Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol. 1992;166:781-787.
25. Buekers TE, Lallas TA. Chemotherapy in pregnancy. Obstet Gynecol Clin North Am. 1998;25:323-329. (Pubitemid 28272324)
26. Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001;2:173-177. (Pubitemid 34092723)
27. Hahn KM, Johnson PH, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107:1219-1226. (Pubitemid 44452769)
28. Van Calsteren K, Berteloot P, Hanssens M, et al. In utero exposure to chemotherapy: effect on cardiac and neurologic outcome. J Clin Oncol. 2006;24:e16-e17.
29. Amant F, Van Calsteren K, Halaska MJ, et al. Gynecologic cancers in pregnancy: guidelines of an international consensus meeting. Int J Gynecol Cancer. 2009;19(suppl 1):S1-S12.
30. Greskovich JF Jr, Macklis RM. Radiation therapy in pregnancy: risk calculation and risk minimization. Semin Oncol. 2000;27:633-645.
31. Streffer C, Shore R, Konermann G, et al. Biological effects after prenatal irradiation (embryo and fetus). A report of the International Commission on Radiological Protection. Ann ICRP. 2003;33:5-206.
32. Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol. 2005;6:328-333. (Pubitemid 40590270)
33. Abadi U, Koren G, Lishner M. Leukemia and lymphoma in pregnancy. Hematol Oncol Clin North Am. 2011;25:277-291, vii.
34. Lew PS, Tan WC, Tan WK, et al. Dilemmas in management of brain tumours in pregnancy. Ann Acad Med Singapore. 2010;39:64-65.
35. McGrane J, Bedford T, Kelly S. Successful pregnancy and delivery after concomitant temozolomide and radiotherapy treatment of glioblastoma multiforme. Clin Oncol (R Coll Radiol). 2012;24:311.
36. Merimsky O, Le Chevalier T, Missenard G, et al. Management of cancer in pregnancy: a case of Ewing's sarcoma of the pelvis in the third trimester. Ann Oncol. 1999;10:345-350. (Pubitemid 29217228)
37. Schur S, Wild J, Amann G, et al. Sarcoma of the ewing family in pregnancy: a case report of intrauterine fetal death after induction of chemotherapy. Case Rep Oncol. 2012;5:633-638.
38. Dildy GA III, Moise KJ Jr, Carpenter RJ Jr, et al. Maternal malignancy metastatic to the products of conception: a review. Obstet Gynecol Surv. 1989;44:535-540. (Pubitemid 19170854)
39. Sebire NJ, Jauniaux E. Fetal and placental malignancies: prenatal diagnosis and management. Ultrasound Obstet Gynecol. 2009;33:235-244.
40. Moller D, Ipsen L, Asschenfeldt P. Fatal course of malignant melanoma during pregnancy with dissemination to the products of conception. Acta Obstet Gynecol Scand. 1986;65:501-502. (Pubitemid 16015194)
41. Cramblett HG, Friedman JL, Najjar S. Leukemia in an infant born of a mother with leukemia. N Engl J Med. 1958;259:727-729.
42. Brodsky I, Baren M, Kahn SB, et al. Metastatic malignant melanoma from mother to fetus. Cancer. 1965;18:1048-1054.
43. Smith LH, Danielsen B, Allen ME, et al. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol. 2003;189:1128-1135. (Pubitemid 37373909)
44. Stensheim H, Moller B, van Dijk T, et al. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol. 2009;27:45-51.
45. Haerr RW, Pratt AT. Multiagent chemotherapy for sarcoma diagnosed during pregnancy. Cancer. 1985;56:1028-1033. (Pubitemid 15003481)
46. Simon MA, Phillips WA, Bonfiglio M. Pregnancy and aggressive or malignant primary bone tumors. Cancer. 1984; 53:2564-2569. (Pubitemid 14102504)
47. Huvos AG, Butler A, Bretsky SS. Osteogenic sarcoma in pregnant women. Prognosis, therapeutic implications, and literature review. Cancer. 1985;56:2326-2331. (Pubitemid 16236615)
48. Merimsky O, Isakov J, Kollender Y, et al. Vascular invasion in high grade sarcoma of the extremity is associated with short overall survival. Oncol Rep. 1998;5:985-989. (Pubitemid 28270708)
49. Stevenson CB, Thompson RC. The clinical management of intracranial neoplasms in pregnancy. Clinical Obstet Gynecol. 2005;48:24-37. (Pubitemid 40354371)
50. Burrow GN, Ferris TF. Medical Complications During Pregnancy. 2nd ed. Philadelphia, PA: Saunders; 1982.
51. Tomson T, Landmark CJ, Battino D. Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications. Epilepsia. 2013;54:405-414.
52. Sneed PK, Albright NW, Wara WM, et al. Fetal dose estimates for radiotherapy of brain tumors during pregnancy. Int J Radiat Oncol Biol Phys. 1995;32:823-830.
53. Nishio S, Morioka T, Suzuki S, et al. Primary brain tumours manifesting during pregnancy: presentation of six cases and a review of the literature. J Clin Neurosci. 1996;3:334-337. (Pubitemid 126658506)
54. Tewari KS, Cappuccini F, Asrat T, et al. Obstetric emergencies precipitated by malignant brain tumors. Am J Obstet Gynecol. 2000;182:1215-1221. (Pubitemid 30353314)
55. Johnson N, Sermer M, Lausman A, et al. Obstetric outcomes of women with intracranial neoplasms. Int J Gynaecol Obstet. 2009;105:56-59.
56. Wu J, Ma YH, Wang TL. Glioma in the third trimester of pregnancy: two cases and a review of the literature. Oncol Lett. 2013;5:943-946.
57. Chaudhuri P, Wallenburg HC. Brain tumors and pregnancy. Presentation of a case and a review of the literature. Eur J Obstet Gynecol Reprod Biol. 1980;11:109-114. (Pubitemid 11240649)
58. Lee LS, Chi CW, Chang TJ, et al. Steroid hormone receptors in meningiomas of Chinese patients. Neurosurgery. 1989; 25:541-545.
59. Lynch JC, Gouvea F, Emmerich JC, et al. Management strategy for brain tumour diagnosed during pregnancy. Br J Neurosurg. 2011;25:225-230.
60. Pallud J, Duffau H, Razak RA, et al. Influence of pregnancy in the behavior of diffuse gliomas: clinical cases of a French glioma study group. J Neurol. 2009;256:2014-2020.
61. Roelvink NC, Kamphorst W, van Alphen HA, et al. Pregnancyrelated primary brain and spinal tumors. Arch Neurol. 1987; 44:209-215. (Pubitemid 17002605)
62. Azim HA Jr, Peccatori FA, Pavlidis N. Lung cancer in the pregnant woman: to treat or not to treat, that is the question. Lung Cancer. 2010;67:251-256.
63. Boussios S, Han SN, Fruscio R, et al. Lung cancer in pregnancy: report of nine cases from an international collaborative study. Lung Cancer. 2013;82:499-505.
64. Garrido M, Clavero J, Huete A, et al. Prolonged survival of a woman with lung cancer diagnosed and treated with chemotherapy during pregnancy. Review of cases reported. Lung Cancer. 2008;60:285-290. (Pubitemid 351609141)
65. Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist. 2002;7:279-287. (Pubitemid 34919954)
66. Sariman N, Levent E, Yener NA, et al. Lung cancer and pregnancy. Lung Cancer. 2013;79:321-323.
67. Stark P, Greene RE, Morgan G, Hildebrandt-Stark HE. Lung cancer and pregnancy. Radiologe. 1985;25:30-32. (Pubitemid 15168841)
68. Kamal Y, Sheehan S, Geary M. Gastric carcinoma: an unusual cause of vomiting in pregnancy. J Obstet Gynaecol. 2004; 24:820. (Pubitemid 39643470)
69. Sakamoto K, Kanda T, Ohashi M, et al. Management of patients with pregnancy-associated gastric cancer in Japan: a mini-review. Int J Clin Oncol. 2009;14:392-396.
70. Jaspers VK, Gillessen A, Quakernack K. Gastric cancer in pregnancy: do pregnancy, age or female sex alter the prognosis? Case reports and review. Eur J Obstet Gynecol Reprod Biol. 1999;87:13-22. (Pubitemid 29440846)
71. Ueo H, Matsuoka H, Tamura S, et al. Prognosis in gastric cancer associated with pregnancy. World J Surg. 1991;15: 293-297, discussion 298.
72. Alexander A, Samlowski WE, Grossman D, et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol. 2003;21:2179-2186. (Pubitemid 46606367)
73. Reynoso EE, Shepherd FA, Messner HA, et al. Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol. 1987;5:1098-1106. (Pubitemid 18056018)
74. Hurley TJ, McKinnell JV, Irani MS. Hematologic malignancies in pregnancy. Obstet Gynecol Clin North Am. 2005;32: 595-614. (Pubitemid 41718953)
75. Cullins SL, Pridjian G, Sutherland CM. Goldenhar's syndrome associated with tamoxifen given to the mother during gestation. JAMA . 1994;271:1905-1906. (Pubitemid 24177092)
76. Mechery J, Ikhena SE. Cancer of the descending colon during pregnancy. J Obstet Gynaecol. 2007;27:311-312. (Pubitemid 46676410)
77. Molkenboer JF, Vos AH, Schouten HC, et al. Acute lymphoblastic leukaemia in pregnancy. Neth JMed. 2005;63: 361-363. (Pubitemid 41748591)
78. Caligiuri MA, Mayer RJ. Pregnancy and leukemia. Semin Oncol. 1989;16:388-396. (Pubitemid 19259011)
79. Catanzarite VA, Ferguson JE II. Acute leukemia and pregnancy: a review of management and outcome, 1972-1982. Obstet Gynecol Surv. 1984;39:663-678. (Pubitemid 15223041)
80. Greenlund LJ, Letendre L, Tefferi A. Acute leukemia during pregnancy: a single institutional experience with 17 cases. Leuk Lymphoma. 2001;41:571-577. (Pubitemid 32717309)
81. Rizack T, Mega A, Legare R, et al. Management of hematological malignancies during pregnancy. Am J Hematol. 2009; 84:830-841.
82. Ali R, Ozkalemkas F, Ozkocaman V, et al. Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with leukapheresis during pregnancy: a case report and review of the literature. Jpn J Clin Oncol. 2004;34:215-217. (Pubitemid 43102900)
83. Broccia G, Casula P, Andria M. Chronic myelocytic leukemia in pregnancy: report of a case treated with leukapheresis. Tumori. 1984;70:371-374. (Pubitemid 14039249)
84. Lishner M, Zemlickis D, Degendorfer P, et al. Maternal and foetal outcome following Hodgkin's disease in pregnancy. Br J Cancer. 1992;65:114-117.
85. Ward FT, Weiss RB. Lymphoma and pregnancy. Semin Oncol. 1989;16:397-409. (Pubitemid 19259012)
86. Connors JM. Challenging problems: coincident pregnancy, HIV infection, and older age. Hematology Am Soc Hematol Educ Program. 2008:334-339.
87. Evens AM, Advani R, Press OW, et al. Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis. J Clin Oncol. 2013; 31:4132-4139.
88. Pereg D, Koren G, Lishner M. The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy. Haematologica. 2007;92:1230-1237. (Pubitemid 350144182)
89. Bachanova V, Connors JM. Hodgkin lymphoma in pregnancy. Curr Hematol Malig Rep. 2013;8:211-217.
90. Shapira T, Pereg D, Lishner M. How I treat acute and chronic leukemia in pregnancy. Blood Rev. 2008;22:247-259.
91. Mubarak AA, Kakil IR, Awidi A, et al. Normal outcome of pregnancy in chronic myeloid leukemia treated with interferonalpha in 1st trimester: report of 3 cases and review of the literature. Am J Hematol. 2002;69:115-118. (Pubitemid 34111163)
92. Kasenda B, Ruckert A, Farthmann J, et al. Management of multiple myeloma in pregnancy: strategies for a rare challenge. Clin Lymphoma Myeloma Leuk. 2011;11:190-197.
93. Dabrowska DM, Gore C, Griffiths S, et al. Anaesthetic management of a pregnant patient with multiple myeloma. Int J Obstet Anesth. 2010;19:336-339.
94. Bernstein MA, Madoff RD, Caushaj PF. Colon and rectal cancer in pregnancy. Dis Colon Rectum. 1993;36:172-178. (Pubitemid 23057764)
95. Lambe M, Hsieh C, Trichopoulos D, et al. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994;331:5-9. (Pubitemid 24195593)
96. Andersson TM, Johansson AL, Hsieh CC, et al. Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol. 2009;114:568-572.
97. Van Calsteren K, Heyns L, De Smet F, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol. 2010; 28:683-689.
98. Anderson BO, Petrek JA, Byrd DR, et al. Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger. Ann Surg Oncol. 1996;3:204-211. (Pubitemid 126729511)
99. Novotny DB, Maygarden SJ, Shermer RW, et al. Fine needle aspiration of benign and malignant breast masses associated with pregnancy. Acta Cytol. 1991;35:676-686.
100. Gentilini O, Cremonesi M, Toesca A, et al. Sentinel lymph node biopsy in pregnant patients with breast cancer. Eur J Nucl Med Mol Imaging. 2010;37:78-83.
101. Khera SY, Kiluk JV, Hasson DM, et al. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J. 2008;14:250-254. (Pubitemid 351678056)
102. Elledge RM, Ciocca DR, Langone G, et al. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Cancer. 1993;71:2499-2506. (Pubitemid 23100483)
103. Middleton LP, Amin M, Gwyn K, et al. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer. 2003;98:1055-1060. (Pubitemid 37022108)
104. Reed W, Hannisdal E, Skovlund E, et al. Pregnancy and breast cancer: a population-based study. Virchows Arch. 2003;443:44-50. (Pubitemid 36920950)
105. Cullinane CA, Lubinski J, Neuhausen SL, et al. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer. 2005;117:988-991. (Pubitemid 41688574)
106. Johannsson O, Loman N, Borg A, et al. Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers. Lancet. 1998;352:1359-1360. (Pubitemid 28510925)
107. Shen T, Vortmeyer AO, Zhuang Z, et al. High frequency of allelic loss of BRCA2 gene in pregnancy-associated breast carcinoma. J Natl Cancer Inst. 1999;91:1686-1687. (Pubitemid 29479939)
108. Loman N, Johannsson O, Kristoffersson U, et al. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst. 2001;93:1215-1223. (Pubitemid 32816196)
109. Scott-Conner CE, Schorr SJ. The diagnosis and management of breast problems during pregnancy and lactation. Am J Surg. 1995;170:401-405.
110. Woo JC, Yu T, Hurd TC. Breast cancer in pregnancy: a literature review. Arch Surg. 2003;138:91-98; discussion 99. (Pubitemid 36055657)
111. Nettleton J, Long J, Kuban D, et al. Breast cancer during pregnancy: quantifying the risk of treatment delay. Obstet Gynecol. 1996;87:414-418. (Pubitemid 26075081)
112. Ulery M, Carter L, McFarlin BL, et al. Pregnancy-associated breast cancer: significance of early detection. J Midwifery Womens Health. 2009;54:357-363.
113. Ishida T, Yokoe T, Kasumi F, et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res. 1992;83:1143-1149. (Pubitemid 23009034)
114. Liberman L, GiessCS, DershawDD, et al. Imaging of pregnancyassociated breast cancer. Radiology. 1994;191:245-248.
115. Samuels TH, Liu FF, Yaffe M, et al. Gestational breast cancer. Can Assoc Radiol J. 1998;49:172-180. (Pubitemid 28340419)
116. Dominici LS, Kuerer HM, Babiera G, et al. Wound complications from surgery in pregnancy-associated breast cancer (PABC). Breast Dis. 2010;31:1-5.
117. Nicklas AH, Baker ME. Imaging strategies in the pregnant cancer patient. Semin Oncol. 2000;27:623-632.
118. Rojansky N, Shushan A, Livni N, et al. Pregnancy associated with colon carcinoma overexpressing p53. Gynecol Oncol. 1997;64:516-520. (Pubitemid 27120449)
119. Tewari K, Bonebrake RG, Asrat T, et al. Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancet. 1997; 350:183. (Pubitemid 27303627)
120. Kincannon J, Boutzale C. The physiology of pigmented nevi. Pediatrics. 1999;104(pt 2):1042-1045. (Pubitemid 29463550)
121. Goldstein BG, Goldstein AO. Diagnosis and management of malignant melanoma. Am Fam Physician. 2001;63:1359-1368, 1374. (Pubitemid 32322828)
122. Keleher A, Wendt R III, Delpassand E, et al. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J. 2004;10:492-495. (Pubitemid 39524981)
123. Annane K, Bellocq JP, Brettes JP, et al. Infiltrative breast cancer during pregnancy and conservative surgery. Fetal Diagn Ther. 2005;20:442-444. (Pubitemid 41197072)
124. Kuerer HM, Gwyn K, Ames FC, et al. Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery. 2002;131:108-110. (Pubitemid 34118604)
125. Mondi MM, Cuenca RE, Ollila DW, et al. Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol. 2007;14:218-221. (Pubitemid 44954292)
126. Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med. 2004;29:564-575; discussion 524. (Pubitemid 40039994)
127. Berry DL, Theriault RL, Holmes FA, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol. 1999;17:855-861. (Pubitemid 29109315)
128. Mir O, Berveiller P, Goffinet F, et al. Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol. 2010;21: 425-426.
129. Isaacs RJ, Hunter W, Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy-case report and literature review. Gynecol Oncol. 2001;80:405-408. (Pubitemid 32207545)
130. O'Meara AT, Cress R, Xing G, et al. Malignant melanoma in pregnancy. A population-based evaluation. Cancer. 2005; 103:1217-1226. (Pubitemid 40328093)
131. Zagouri F, Sergentanis TN, Chrysikos D, et al. Trastuzumab administration during pregnancy: a systematic review-and metaanalysis. Breast Cancer Res Treat. 2013; 137:349-357.
132. Jones AL. Management of pregnancy-associated breast cancer. Breast. 2006;15(suppl 2):S47-S52. (Pubitemid 46432152)
133. Longo SA, Moore RC, Canzoneri BJ, et al. Gastrointestinal conditions during pregnancy. Clin Colon Rectal Surg. 2010; 23:80-89.
134. Saif MW. Management of colorectal cancer in pregnancy: a multimodality approach. Clin Colorectal Cancer. 2005;5: 247-256.
135. Dahling MT, Xing G, Cress R, et al. Pregnancy-associated colon and rectal cancer: perinatal and cancer outcomes. J Matern Fetal Neonatal Med. 2009;22:204-211.
136. Lolis ED, Likoudis P, Voiniadis P, et al. Synchronous rectal and colon cancer caused by familial polyposis coli during pregnancy. J Obstet Gynaecol Res. 2007;33:199-202. (Pubitemid 46376408)
137. Cooper DS. Thyroid hormone treatment: new insights into an old therapy. JAMA. 1989;261:2694-2695. (Pubitemid 19127966)
138. Lamerz R, Ruider H, et al. Significance of CEA determinations in patients with cancer of the colon-rectum and the mammary gland in comparison to physiological states in connection with pregnancy. Bull Cancer. 1976.63:575-586. (Pubitemid 8039099)
139. Saif MW. Management of colorectal cancer in pregnancy: a multimodality approach. Clin Colorectal Cancer. 2005;5: 247-256.
140. Nies C, Leppek R, Sitter H, et al. Prospective evaluation of different diagnostic techniques for the detection of liver metastases at the time of primary resection of colorectal carcinoma. Eur J Surg. 1996;162:811-816.
141. Seidman DS, Ben-Ari GY, Heyman Z, et al. Use of magnetic resonance imaging in pregnancy to diagnose intussusception induced by colonic cancer. Obstet Gynecol. 1992;79: 822-823.
142. Minter A, Malik R, Ledbetter L, et al. Colon cancer in pregnancy. Cancer Control: Journal of the Moffitt Cancer Center. 2005;12:196-202. (Pubitemid 41060183)
143. Walsh C, Fazio VW. Cancer of the colon, rectum, and anus during pregnancy. The surgeon's perspective. Gastroenterol Clin North Am. 1998;27:257-267. (Pubitemid 28156198)
144. Antonelli NM, Dotters DJ, Katz VL, et al. Cancer in pregnancy: a review of the literature. Part II. Obstet Gynecol Surv. 1996;51:135-142. (Pubitemid 26044400)
145. Taylor J, Amanze A, Di Federico E, et al. Irinotecan use during pregnancy. Obstet Gynecol. 2009;114(pt 2):451-452.
146. Ochshorn Y, Kupferminc MJ, Lessing JB, et al. Rectal carcinoma during pregnancy: a reminder and updated treatment protocols. Eur J Obstet Gynecol Reprod Biol. 2000;91:201-202. (Pubitemid 30408332)
147. Rothman LA, Cohen CJ, Astarloa J. Placental and fetal involvement by maternal malignancy: a report of rectal carcinoma and review of the literature. Am J Obstet Gynecol. 1973;116:1023-1034.
148. Bleyer A, Viny A, Barr R. Cancer in 15-to 29-year-olds by primary site. Oncologist. 2006;11:590-601. (Pubitemid 43967614)
149. Weir HK, Marrett LD, Cokkinides V, et al. Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006. J Am Acad Dermatol. 2011;65(suppl 1):S38-S49.
150. Dillman RO, Vandermolen LA, Barth NM, et al. Malignant melanoma and pregnancy ten questions. West J Med. 1996; 164:156-161.
151. Beyeler M, Hafner J, Beinder E, et al. Special considerations for stage IV melanoma during pregnancy. Arch Dermatol. 2005;141:1077-1079. (Pubitemid 41373950)
152. Karagas MR, Zens MS, Stukel TA, et al. Pregnancy history and incidence of melanoma in women: a pooled analysis. Cancer Causes Control. 2006;17:11-19. (Pubitemid 43083665)
153. Lens MB, Rosdahl I, Ahlbom A, et al. Effect of pregnancy on survival in women with cutaneous malignant melanoma. J Clin Oncol. 2004;22:4369-4375. (Pubitemid 41185157)
154. MacKieRM, Bufalino R, Morabito A, et al. Lack of effect of pregnancy on outcome of melanoma. For The World Health Organisation Melanoma Programme. Lancet. 1991;337:653-655.
155. McManamny DS, Moss AL, Pocock PV, et al. Melanoma and pregnancy: a long-term follow-up. Br J Obstet Gynaecol. 1989;96:1419-1423. (Pubitemid 20020050)
156. Baergen RN, Johnson D, Moore T, et al. Maternal melanoma metastatic to the placenta: a case report and review of the literature. Arch Pathol Lab Med. 1997;121:508-511.
157. Gottschalk N, Jacobs VR, Hein R, et al. Advanced metastatic melanoma during pregnancy: a multidisciplinary challenge. Onkologie. 2009;32:748-751.
158. Kung AW, Chau MT, Lao TT, et al. The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metabo. 2002; 87:1010-1014. (Pubitemid 36121056)
159. Struve CW, Haupt S, Ohlen S. Influence of frequency of previous pregnancies on the prevalence of thyroid nodules in women without clinical evidence of thyroid disease. Thyroid. 1993;3:7-9.
160. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21:1081-1125.
161. Mazzaferri EL. Approach to the pregnant patient with thyroid cancer. J Clin Endocrinol Metab. 2011;96:265-272.
162. Moosa M, Mazzaferri EL. Outcome of differentiated thyroid cancer diagnosed in pregnant women. J clin endocrinol metab. 1997;82:2862-2866. (Pubitemid 27385640)
163. Nam KH, Yoon JH, Chang HS, et al. Optimal timing of surgery in well-differentiated thyroid carcinoma detected during pregnancy. J Surg Oncol. 2005;91:199-203. (Pubitemid 41254424)
164. Yasmeen S, Cress R, Romano PS, et al. Thyroid cancer in pregnancy. Int J Gynaecol Obstet. 2005;91:15-20. (Pubitemid 41278554)